Li, Xia http://orcid.org/0000-0001-7765-0333
Frechen, Sebastian
Moj, Daniel
Lehr, Thorsten
Taubert, Max
Hsin, Chih-hsuan
Mikus, Gerd
Neuvonen, Pertti J.
Olkkola, Klaus T.
Saari, Teijo I.
Fuhr, Uwe http://orcid.org/0000-0001-7087-5871
Funding for this research was provided by:
China Scholarship Council (201406920024)
Hospital District of South-West Finland (#13821)
Article History
First Online: 19 December 2019
Compliance with Ethical Standards
:
: XL obtained financial support provided by the China Scholarship Council during the study and during manuscript preparation (No. 201406920024). TIS obtained a governmental research grant (#13821) from the Hospital District of South-West Finland to support his work.
: Sebastian Frechen is an employee and potential shareholder of Bayer AG, Leverkusen, Germany. Xia Li, Daniel Moj, Thorsten Lehr, Max Taubert, Chih-hsuan Hsin, Gerd Mikus, Pertti J. Neuvonen, Klaus T. Olkkola, Teijo I. Saari, and Uwe Fuhr have no conflicts of interest to declare.